The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran

Journal of Endocrinological Investigation

Volumn 35, Issue 5, 2012, Pages 516-521

  Delshad, H ^a   Mehran, L ^a   Tohidi, M ^b   Assadi, M ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyperthyroidism; Hypothyroidism; Incidence; Natural history; Subclinical thyroid disorders; Thyroid diseases

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GOITER; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION; THYROID NODULE; THYROID SURGERY; THYROTROPIN BLOOD LEVEL; URBAN AREA;

ADULT; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IODIDE PEROXIDASE; IRAN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84863903569     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7968     Document Type: Article

References (56)

1. Carlé A, Laurberg P, Pedersen IB, et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol 2006, 154: 21-8. (Pubitemid 43250732)
2. Bülow Pedersen I, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab 2002, 87: 4462-9. (Pubitemid 35247026)
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489-99. (Pubitemid 34158210)
4. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43: 55-68.
5. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP. The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 2004, 89: 3879-84. (Pubitemid 39071488)
6. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998, 83: 765-9. (Pubitemid 28496981)
7. Ceresini G, Morganti S, Maggio M, et al. Subclinical thyroid disease in elderly subjects. Acta Biomed 2010, 81 (Suppl 1): 31-6.
8. Wilson S, Parle JV, Roberts LM, et al Birmingham Elderly Thyroid Study Team. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocrinol Metab 2006, 91: 4809-16. (Pubitemid 44917312)
9. Laurberg P, Bülow Pedersen I, Pedersen KM, Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake. Thyroid 1999, 9: 33-8. (Pubitemid 29081148)
10. Galofré JC, García-Mayor RV, Fluiters E, et al. Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area. Thyroidology 1994, 6: 49-54.
11. Cerdá Gabaroi D, Peris P, Monegal A, et al. Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause 2010, 17: 135-9.
12. Duntas LH, Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 2007, 17: 1075-84. (Pubitemid 350207760)
13. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med 2006, 260: 53-61. (Pubitemid 43894070)
14. Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med 2003, 18: 146-53.
15. Sengül E, Cetinarslan B, Tarkun I, Cantürk Z, Türemen E. Homocysteine concentrations in subclinical hypothyroidism. Endocr Res 2004, 30: 351-9. (Pubitemid 39456440)
16. Aldasouqi S, Nkansa-Dwamena D, Bokhari S, et al. Is subclinical hypothyroidism associated with hyperhomocysteinemia? Endocr Pract 2004, 10: 399-403.
17. Deicher R, Vierhapper H. Homocysteine: a risk factor for cardiovascular disease in subclinical hypothyroidism? Thyroid 2002, 12: 733-6. (Pubitemid 34913247)
18. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006, 295: 1033-41.
19. Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel RM. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol 2010, 162: 569-77.
20. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005, 165: 2460-6. (Pubitemid 41720006)
21. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 2008, 20: 1101-14.
22. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007, 32: 49-65.
23. Knudsen N, Bülow I, Jørgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol 2000, 143: 485-91.
24. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) 1999, 51: 361-7. (Pubitemid 29439057)
25. Bjoro T, Holmen J, Krüger O, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol 2000, 143: 639-47.
26. Vanderpump MP. Epidemiology of Thyroid Dysfunction - Hypothyroidism and Hyperthyroidism. Thyroid International 2009, 2: 1-12.
27. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526-34. (Pubitemid 30112276)
28. Brownlie BE, Wells JE. The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol (Oxf) 1990, 33: 249-59. (Pubitemid 20233601)
29. Berglund J, Ericsson UB, Hallengren B. Increased incidence of thyrotoxicosis in Malmö during the years 1988-1990 as compared to the years 1970-1974. J Intern Med 1996, 239: 57-62.
30. th ed. Oxford University Press. 2008, 398-406.
31. Arber N, Schapiro JM, Lapidot M, et al. High incidence of occult thyroid disease among general medical ward patients. J Med 1995, 26: 139-51.
32. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007, 17: 1211-23.
33. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92: 4575-82. (Pubitemid 350223429)
34. Klubo-Gwiezdzinska J, Wartofsky L. Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient. Arch Intern Med 2009, 169: 1949-51.
35. Azizi F, Mehran L, Sheikholeslam R, et al. Sustainability of a well-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt. J Endocrinol Invest 2008, 31: 422-31. (Pubitemid 352003236)
36. Delshad H, Mehran L, Azizi F. Appropriate iodine nutrition in Iran: 20 years of success. Acta Med Iran 2010, 48: 361-6.
37. Heydarian P, Ordookhani A, Azizi F. Goiter rate, serum thyrotropin, thyroid autoantibodies and urinary iodine concentration in Tehranian adults before and after national salt iodization. J Endocrinol Invest. 2007, 30: 404-10. (Pubitemid 47098236)
38. Jones DD, May KE, Geraci SA. Subclinical thyroid disease. Am J Med 2010, 123: 502-4.
39. Sundbeck G, Lundberg PA, Lindstedt G, Jagenburg R, Edén S. Incidence and prevalence of thyroid disease in elderly women: results from the longitudinal population study of elderly people in Gothenburg, Sweden. Age Ageing 1991, 20: 291-8.
40. Leese GP, Flynn RV, Jung RT, Macdonald TM, Murphy MJ, Morris AD. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 2008, 68: 311-6.
41. Li Y, Teng D, Shan Z, et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes, J Clin Endocrinol Metab 2008, 93: 1751-7. (Pubitemid 351656514)
42. Kabadi UM. 'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993, 153: 957-61 (Pubitemid 23124736)
43. Diez JJ, Iglesias P. An analysis of the natural course of subclinical hyperthyroidism. Am J Med Sci 2009, 337: 225-32
44. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence and regression of thyroid diseases in adolescents and young adults. Am J Med 1991, 91: 363-70.
45. Gopinath B, Wang JJ, Kifley A, et al. Five-year incidence and progression of thyroid dysfunction in an older population. Intern Med J 2010, 40: 642-9.
46. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study. Clin Endocrinol (Oxf) 2010, 72: 685-8.
47. Baloch Z, Carayon P, Conte-Devolx B, et al Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3-126.
48. Boucai L, Surks MI. Surks, Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clinical Endocrinology 2009, 70: 788-93.
49. Surks MI. Should the upper limit of the normal reference range for TSH be lowered? Nat Clin Pract Endocrinol Metab 2008, 4: 370-1. (Pubitemid 351881860)
50. Kratzsch J, Schubert G, Pulzer F, et al. Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of life. Clin Biochem 2008, 41: 1091-8.
51. Ward LS. Should we change the reference values of normal TSH? Arq Bras Endocrinol Metabol 2008, 52: 141-2.
52. Guan H, Shan Z, Teng X, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008, 69: 136-41. (Pubitemid 351863590)
53. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007, 92: 4236-40. (Pubitemid 350074737)
54. Eskelinen S, Suominen P, Vahlberg T, et al. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population. Clin Chem Lab Med 2005, 43: 1380-5. (Pubitemid 41752569)
55. Kratzsch J, Fielder GM, Leichtle A, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005, 51: 1480-6. (Pubitemid 41060881)
56. Hamilton TE, Davis S, Onstad L, Kopecky KJ. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008, 93: 1224-30. (Pubitemid 351519714)